morcares™ Platform
BCSS Initiative
A Select Cancer Diagnostics Platform
CHIL is opening a focused investment opportunity around a cancer diagnostics platform designed to address a clear and persistent gap in early access and screening. Developed through years of in-house research and validated through a disciplined, founder-led approach, this platform is now ready to move forward with aligned strategic partners.
Engagement is structured, selective, and purpose-driven, offering participation at the platform or project level for investors who share a long-term perspective on valuation, scalability, and responsible growth.
Details are intentionally shared through private dialogue only, ensuring alignment, discretion, and a shared vision from the outset.
